Literature DB >> 21223687

[Clinicopathological features and prognostic implications of EGFR/c-Met gene copy number and protein expression in non-small cell lung cancer].

Ting Ai1, Ning Wang, Wei-wei Li, Li-ping Song.   

Abstract

OBJECTIVE: To investigate the gene copy number and protein expression of EGFR/c-Met, so as to explore the relationship between them and the clinicopathological features and prognosis in non-small cell lung cancer (NSCLC) patients.
METHODS: The expression of EGFR/c-Met protein was detected by immunohistochemical staining in NSCLC tissues of 61 cases. The level of EGFR/c-Met gene copy number was detected by fluorescent RT-PCR.
RESULTS: The positive rates of EGFR and c-Met protein expression were 77.5% and 57.4%, respectively. These rates in well/moderately differentiated NSCLC tissues were 61.5% and 38.5%, all significantly lower than the data in poorly differentiated tissues (P < 0.05). The relative EGFR and c-Met gene copy number was 0.22 ± 0.22 and 0.20 ± 0.21 in smokers, respectively, all significantly higher than that in non-smokers (P < 0.05). The gene copy number of EGFR and c-Met in adenocarcinoma was 0.24 ± 0.26 and 0.23 ± 0.25, respectively, all higher than the data in squamous cell carcinoma (P < 0.05). There was a significant correlation in regard to the EGFR and c-Met protein expression, EGFR and c-Met gene copy number, and the protein expression vs. the gene copy number only in EGFR (P < 0.05). But there was no significant correlation between the c-Met protein expression and gene copy number (P = 0.259). There was a statistical significance between the postoperational median survival times (MST) of low EGFR gene copy number (48 months) and the high EGFR gene copy number (36 months) patients (P = 0.039). Similarly, there was also a significant difference between the MST of the low and high c-Met gene copy number patients (44 and 31 months, P = 0.022).
CONCLUSION: There is a correlation between the EGFR and c-Met protein expression and the differentiation of NSCLC. The relative gene copy number is correlated with pathologic types and smoking of NSCLC patients, and it can be used in the prediction of prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21223687

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  1 in total

1.  Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit.

Authors:  Debora de Melo Gagliato; Denis L Fontes Jardim; Gerald Falchook; Chad Tang; Ralph Zinner; Jennifer J Wheler; Filip Janku; Vivek Subbiah; Sarina A Piha-Paul; Siqing Fu; Kenneth Hess; Sinchita Roy-Chowdhuri; Stacy Moulder; Ana M Gonzalez-Angulo; Funda Meric-Bernstam; David S Hong
Journal:  Clin Breast Cancer       Date:  2014-06-23       Impact factor: 3.225

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.